Ocugen (OCGN) Other Non Operating Income (2014 - 2026)
Ocugen (OCGN) reported Other Non Operating Income of -$150000.0 for Q1 2026, down 330.77% on a YoY basis from $65000.0 in Q1 2025, and down 131.45% quarter-over-quarter from $477000.0 in Q4 2025.
Ocugen (OCGN) Other Non Operating Income (2014 - 2026) Analysis & Trends
Ocugen has reported Other Non Operating Income for 12 years, with the latest figure at -$150000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 330.77% year-over-year to -$150000.0; the trailing twelve-month figure through Mar 2026 stood at -$927000.0 (down 496.15% YoY), and the FY2025 full-year result was -$664000.0, down 574.29% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$150000.0, down from $477000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $477000.0 in Q4 2025, with the low at -$1.3 million in Q3 2025.
- Historically, Other Non Operating Income has averaged -$108285.7 across 4 years, with a median of $15000.0 in 2022.
- The largest YoY upside for Other Non Operating Income was 211.76% in 2025 against a maximum downside of 132000.0% in 2025.
- Ocugen's Other Non Operating Income stood at $15000.0 in 2022, then surged by 920.0% to $153000.0 in 2024, then surged by 211.76% to $477000.0 in 2025, then slumped by 131.45% to -$150000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$150000.0 (Q1 2026), $477000.0 (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -150,000.00 |
| Dec 31, 2025 | 477,000.00 |
| Sep 30, 2025 | -1.32 Mn |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 153,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 336,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -332,000.00 |
| Mar 31, 2021 | -20,000.00 |
| Mar 31, 2020 | -87.00 |
| Dec 31, 2019 | 19.11 Mn |
| Sep 30, 2019 | -18.51 Mn |
| Jun 30, 2019 | 184.00 |
| Mar 31, 2019 | -416.00 |
| Dec 31, 2018 | 1.50 Mn |
| Sep 30, 2018 | 7,755.00 |
| Jun 30, 2018 | -26,000.00 |
| Mar 31, 2018 | -24,000.00 |